Cinatratoside B

Details

Top
Internal ID e9cc71b7-6f2b-41e1-897d-e51b671e0ddb
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Oligosaccharides
IUPAC Name (4S,5R,8S,13R,16S,19R,22R)-8-[(2R,4R,5R,6R)-5-[(2S,4S,5S,6R)-4-hydroxy-5-[(2S,4R,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.04,13.05,10.019,22]docosa-1(21),10-dien-14-one
SMILES (Canonical) CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3OC)OC4CCC5(C6CCC7=COC8(C7C(CO8)OC(=O)C6CC=C5C4)C)C)C)C)OC)O
SMILES (Isomeric) C[C@H]1[C@@H]([C@@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@H]3OC)O[C@H]4CC[C@@]5([C@H]6CCC7=CO[C@@]8([C@H]7[C@@H](CO8)OC(=O)[C@@H]6CC=C5C4)C)C)C)C)OC)O
InChI InChI=1S/C41H62O14/c1-20-36(43)29(45-6)16-34(49-20)54-37-21(2)50-32(15-28(37)42)55-38-22(3)51-33(17-30(38)46-7)52-25-12-13-40(4)24(14-25)9-10-26-27(40)11-8-23-18-47-41(5)35(23)31(19-48-41)53-39(26)44/h9,18,20-22,25-38,42-43H,8,10-17,19H2,1-7H3/t20-,21+,22+,25-,26+,27-,28-,29+,30+,31+,32-,33-,34-,35+,36-,37+,38+,40-,41-/m0/s1
InChI Key UTQDRWSHVALSEO-MXHUJVEWSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C41H62O14
Molecular Weight 778.90 g/mol
Exact Mass 778.41395665 g/mol
Topological Polar Surface Area (TPSA) 159.00 Ų
XlogP 2.80
Atomic LogP (AlogP) 4.03
H-Bond Acceptor 14
H-Bond Donor 2
Rotatable Bonds 8

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Cinatratoside B

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9872 98.72%
Caco-2 - 0.8663 86.63%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability - 0.6286 62.86%
Subcellular localzation Mitochondria 0.8323 83.23%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8534 85.34%
OATP1B3 inhibitior + 0.9719 97.19%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.7500 75.00%
BSEP inhibitior + 0.9315 93.15%
P-glycoprotein inhibitior + 0.7519 75.19%
P-glycoprotein substrate + 0.7252 72.52%
CYP3A4 substrate + 0.7391 73.91%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8858 88.58%
CYP3A4 inhibition - 0.8476 84.76%
CYP2C9 inhibition - 0.9148 91.48%
CYP2C19 inhibition - 0.9613 96.13%
CYP2D6 inhibition - 0.9445 94.45%
CYP1A2 inhibition - 0.8823 88.23%
CYP2C8 inhibition + 0.5859 58.59%
CYP inhibitory promiscuity - 0.9502 95.02%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.4604 46.04%
Eye corrosion - 0.9902 99.02%
Eye irritation - 0.9178 91.78%
Skin irritation + 0.5000 50.00%
Skin corrosion - 0.9385 93.85%
Ames mutagenesis - 0.6654 66.54%
Human Ether-a-go-go-Related Gene inhibition + 0.7138 71.38%
Micronuclear - 0.7900 79.00%
Hepatotoxicity - 0.5552 55.52%
skin sensitisation - 0.8945 89.45%
Respiratory toxicity + 0.8000 80.00%
Reproductive toxicity + 0.9556 95.56%
Mitochondrial toxicity + 0.7000 70.00%
Nephrotoxicity - 0.7504 75.04%
Acute Oral Toxicity (c) I 0.5334 53.34%
Estrogen receptor binding + 0.8082 80.82%
Androgen receptor binding + 0.7276 72.76%
Thyroid receptor binding - 0.5582 55.82%
Glucocorticoid receptor binding + 0.7570 75.70%
Aromatase binding + 0.6749 67.49%
PPAR gamma + 0.7574 75.74%
Honey bee toxicity - 0.6350 63.50%
Biodegradation - 0.7000 70.00%
Crustacea aquatic toxicity + 0.5900 59.00%
Fish aquatic toxicity + 0.9456 94.56%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 98.95% 85.14%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.61% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.43% 96.09%
CHEMBL1994 P08235 Mineralocorticoid receptor 93.66% 100.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 92.80% 94.45%
CHEMBL1806 P11388 DNA topoisomerase II alpha 92.37% 89.00%
CHEMBL253 P34972 Cannabinoid CB2 receptor 91.93% 97.25%
CHEMBL1914 P06276 Butyrylcholinesterase 91.87% 95.00%
CHEMBL2581 P07339 Cathepsin D 91.38% 98.95%
CHEMBL3137262 O60341 LSD1/CoREST complex 89.55% 97.09%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 88.62% 99.23%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.61% 95.56%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 87.88% 95.89%
CHEMBL5608 Q16288 NT-3 growth factor receptor 87.49% 95.89%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 86.92% 94.00%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 85.85% 92.62%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 85.74% 97.33%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 84.86% 91.07%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 84.17% 97.14%
CHEMBL1293249 Q13887 Kruppel-like factor 5 82.97% 86.33%
CHEMBL5697 Q9GZT9 Egl nine homolog 1 82.57% 93.40%
CHEMBL3091268 Q92753 Nuclear receptor ROR-beta 82.42% 95.50%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 80.89% 94.33%
CHEMBL5028 O14672 ADAM10 80.28% 97.50%
CHEMBL2335 P42785 Lysosomal Pro-X carboxypeptidase 80.24% 100.00%

Cross-Links

Top
PubChem 21632982
NPASS NPC226284
LOTUS LTS0187881
wikiData Q105279004